Higashiyama RI, Yoshida T, Yagishita S, Ohuchi M, et al. Safety implications of switching pembrolizumab dosage from 200 mg Q3W to 400 mg Q6W in patients with advanced non-small-cell lung cancer. J Thorac Oncol 2022 Jul 1. pii: S1556-0864(22)00314.
PMID: 35788404